Exercise is Medicine: a Cohort Study
EIM-cohort
1 other identifier
interventional
6,000
1 country
1
Brief Summary
6,000 patients with HT and/or DM will be recruited to participate a 12-week EIM exercise intervention, which also involve consistent feedback and reminders using information technology (IT). The primary outcome will be improvement of blood pressure at 1-year. Other clinical outcomes will be obtained on recruitment (baseline), 12-week (immediately after EIM classes) and 1-year after recruitment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jul 2020
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2020
CompletedFirst Posted
Study publicly available on registry
January 31, 2020
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedJuly 16, 2024
July 1, 2024
3.9 years
January 21, 2020
July 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
office blood pressure
office systolic blood pressure
Change from Baseline Systolic Blood Pressure at 3 months
Secondary Outcomes (5)
serum lipid level
baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)
body fat percentage
baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)
body mass index
baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)
international physical activity questionnaire- short form
baseline, 3-month after recruitment (immediate after EIM class), 12-month after recruitment (end-of-study)
office blood pressure
baseline, 12-month after recruitment (end-of-study)
Study Arms (1)
EIM group
EXPERIMENTALThis contains: A 12-week Exercise is medicine teaching class containing 6-18 patients per group (class size may be limited by social distancing policy in Hong Kong), homework are prescribed to participants to encourage regular exercise. The exercise level will be recorded by a tracker and provides feedback to the participants and physical trainer. The physical parameters such as fat percentage and blood pressure level will be feedback to the patients to encourage exercise. (If sports center are closed by the Government, the classes will be conducted online)
Interventions
a 12-week exercise classes program combined with other motivational skills, including feedback and information technology support. The whole program lasts for 1 year for each participant
Eligibility Criteria
You may qualify if:
- have a clinical diagnosis of primary HT and/or type II DM from clinical medical record
- having less than 150 minutes of moderate intensity exercise per week OR having less than 75 minutes of intensive intensity exercise per week (this is set according to latest World Health Organization guideline)
- who have used any mobile apps on their phone (because the intervention involve use of apps to monitor and remind regular exercise)
You may not qualify if:
- patients with diagnosed chronic obstructive lung disease and recent stroke (within last 12 months)
- Patients on 3 or more anti-hypertensive medications (on maximum or maximal tolerable doses) are excluded because these patients have resistant HT and may represent another spectrum of disease.
- Patients with spinal cord compression, radiculopathy with active pain, or osteoarthritis of hips and knees that are on the waiting list for joint replacement surgery are excluded for safety reasons.
- acute myocardial infarction in last 6 months
- ongoing angina
- uncontrolled cardiac arrhythmia
- acute diseases including known active endocarditis/acute pulmonary embolism, pulmonary infarction, deep vein thrombosis, acute aortic dissection, acute myocarditis
- known aortic stenosis
- known heart failure
- known obstructive left main coronary artery stenosis
- uncontrolled ventricular rates
- complete heart block
- known hypertrophic obstructive cardiomyopathy
- mental impairment that limit co-operation
- resting blood pressure with systolic blood pressure \>180mmHg or diastolic blood pressure \>110mmHg
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lek Yuen Clinic
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
January 21, 2020
First Posted
January 31, 2020
Study Start
July 1, 2020
Primary Completion
May 30, 2024
Study Completion
June 30, 2024
Last Updated
July 16, 2024
Record last verified: 2024-07